The St. Vincent de Paul (SVDP) Charitable Pharmacy in Cincinnati, Ohio, announced last week that it surpassed $5.1 million dollars worth of medication dispensed to help people in need since it opened in September 2006 [1]. The Charitable Pharmacy is the only pharmacy in southwest Ohio that provides free, professional pharmaceutical care to people in need.

The U.S. Department of Health and Human Services (HHS) is inviting people to submit comments and suggestions as part of the collaborative process for Healthy People 2020. Healthy People is consortium of diverse, motivated and dedicated agencies and organizations committed to working together to help achieve health goals and objectives for the nation. As a national initiative, Healthy People 2020′s success depends on public input.

Every 10 years, the HHS leverages scientific insights and lessons learned from the past decade, along with knowledge of new and emerging issues, data, trends and innovations to set the nation’s health priorities. In 2007 and 2008, the Healthy People 2020 framework was established, consisting of the vision, mission and overarching goals. In 2009, specific objectives and strategies to achieve them were developed. This month, the HHS is requesting public comments on the draft set of proposed objectives for Healthy People 2020. You are invited to comment on the proposed objectives and topic areas and suggest additional objectives and/or topic areas that you feel are missing.

The American Recovery and Reinvestment Act (ARRA) provided $10 billion for biomedical research, including support for scientific research priorities, extramural construction/repairs/alterations, capital equipment, National Institutes of Health (NIH) buildings and facilities, and comparative effectiveness research [1].

This investment in the future of America’s health has revitalized the biomedical research community. Indeed, in June, the U.S. Department of Health and Human Services (HHS) announced that the Recovery Act drove a record number of NIH grant applications. The stimulus package provides available funds for two years, through September 2010.

This Thanksgiving, Research!America — the nation’s largest non-profit public education and advocacy alliance for discoveries in health — urges everyone to Thank President Obama for Reprioritizing Science and Health. Before year’s end, the President will decide what funding to recommend for NIH. Research!America provides a pre-formatted letter that thanks President Obama for his recommitment to science and urges him to continue making science and health a priority in 2011.

There has been a trend of flat or below-inflation funding for the NIH since 2003. Investment in biomedical research will lead to new medical breakthroughs and discoveries that will benefit everyone by helping to fight disease and improve the quality of life for everyone in America.

Please take a moment to email President Obama and urge him to continue prioritizing science and health in 2011.

References

1. NIH’s Role in the American Recovery and Reinvestment Act (ARRA). National Institutes of Health. 2009 March 6.

Author disclosure of financial associations with commercial entities that have an interest in the research published in medical journals is common practice. The information provided in the disclosure helps readers assess the degree of commercial influence over the work. Recently, however, differing journal policies have led to unintentional omissions and there have been calls for medical journals to standardize their conflict of interest policies.

The 2009 Nobel Prize in Physiology or Medicine was announced earlier this week. The prize was awarded to three U.S. scientists for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase.

Two women, Elizabeth H. Blackburn, age 61, at the University of California in San Francisco, and Carol W. Greider, age 48, at Johns Hopkins University School of Medicine in Baltimore along with one man, Jack W. Szostak, age 57, at Harvard Medical School, will share the $1.4 million prize.